Discover
Foundation Fighting Blindness
Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial

Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial
Update: 2025-10-02
Share
Description
The emerging therapy improved vision for some participants in an earlier clinical trial.
Comments
In Channel